- Home
- IPXX vs VTAK Comparison
IPXX vs VTAK Comparison
Compare IPXX & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPXX
- VTAK
- Stock Information
- Founded
- IPXX 2023
- VTAK 2002
- Country
- IPXX United States
- VTAK United States
- Employees
- IPXX N/A
- VTAK N/A
- Industry
- IPXX Blank Checks
- VTAK Medical/Dental Instruments
- Sector
- IPXX Finance
- VTAK Health Care
- Exchange
- IPXX Nasdaq
- VTAK Nasdaq
- Market Cap
- IPXX 337.5M
- VTAK 1.4M
- IPO Year
- IPXX 2023
- VTAK 2018
- Fundamental
- Price
- IPXX $11.15
- VTAK $0.43
- Analyst Decision
- IPXX
- VTAK
- Analyst Count
- IPXX 0
- VTAK 0
- Target Price
- IPXX N/A
- VTAK N/A
- AVG Volume (30 Days)
- IPXX 13.9K
- VTAK 184.4K
- Earning Date
- IPXX 01-01-0001
- VTAK 11-13-2024
- Dividend Yield
- IPXX N/A
- VTAK N/A
- EPS Growth
- IPXX N/A
- VTAK N/A
- EPS
- IPXX 0.37
- VTAK N/A
- Revenue
- IPXX N/A
- VTAK $399,000.00
- Revenue This Year
- IPXX N/A
- VTAK $637.10
- Revenue Next Year
- IPXX N/A
- VTAK $177.13
- P/E Ratio
- IPXX $30.53
- VTAK N/A
- Revenue Growth
- IPXX N/A
- VTAK 27.07
- 52 Week Low
- IPXX $10.33
- VTAK $0.31
- 52 Week High
- IPXX $15.18
- VTAK $4.10
- Technical
- Relative Strength Index (RSI)
- IPXX 46.82
- VTAK 47.80
- Support Level
- IPXX $10.93
- VTAK $0.34
- Resistance Level
- IPXX $11.45
- VTAK $0.44
- Average True Range (ATR)
- IPXX 0.78
- VTAK 0.04
- MACD
- IPXX -0.12
- VTAK 0.01
- Stochastic Oscillator
- IPXX 6.93
- VTAK 56.15
About IPXX Inflection Point Acquisition Corp. II
Inflection Point Acquisition Corp II is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.